// App-Quantinova.ai

ABS005 : EQUITY IN THE USE OF PROPHYLAXIS IN CHILDREN WITH SEVERE HEMOPHILIA

Researchers

Presenter

  • E. Tootoonchian

Principal Investigators

  • J. Stonebraker

  • M. El Ekiaby

  • E. Gouider

  • A. Iorio

  • M. Makris

  • J. OHara

  • M. Recht

  • G. Pierce

  • D. Coffin

Medical Centers

  • World Federation of Hemophilia, Montreal, Canada

  • North Carolina A&T State University, Greensboro, North Carolina, United States

  • Shabrawichi Hospital, Cairo, Egypt

  • Hôpital Aziza Othmana,Tunis,Tunisia

  • CIMA, University of Sheffield, Sheffield, UK

  • UCL Genomics, London, United Kingdom

  • American Thrombosis Hemostasis Network, Rochester, United States

Locations

  • Canada

  • United States

  • Egypt

  • Tunisia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • Jagged canonical Notch ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved